Program

※Excerpt only international sessions

The following programs listed below are to take place physically on June 18-20 at PACIFICO YOKOHAMA, North. All the programs will be available for live-streaming. On-demand videos are also available for the participants at post-meeting website from July 21 to Aug 4.

Invited Lecture: Novel risk factors for progression of CKD

Date
11:00-11:50, June 18 (Fri)
Venue
Room 1 (G1, North 1F, PACIFICO YOKOHAMA)
Chair
Kunihiro Yamagata
(Department of Nephrology, Division of Clinical Medicine, Faculty of Medicine, University of Tsukuba)
Speaker
Csaba P Kovesdy
(University of Tennessee Health Science Center)

Special Session<Can Japanese evidence change the world?>1
“RCTs on MBD from Japan”

Date
16:00-18:00, June 18 (Fri)
Venue
Room 3 (G303+G304, North 3F, PACIFICO YOKOHAMA)
Chairs
Tadao Akizawa
(Showa University)
Eiichiro Kanda
(Medical Science, Kawasaki Medical School)
1. Moving from pyramid of evidence to yin and yang of evidence: Both RCTs and observational studies guide practice
Noriaki Kurita
(Department of Clinical Epidemiology, Graduate School of Medicine, Fukushima Medical University)
2. The J-DAVID Trial and cardio-protective effects of vitamin D receptor activation
Tetsuo Shoji
(Department of Vascular Medicine, Osaka City University Graduate School of Medicine)
3. Effect of Treating Hyperphosphatemia with Lanthanum Carbonate (LC) vs Calcium Carbonate on Cardiovascular Events in Hemodialysis Patients
Hiroaki Ogata
(Division of Nephrology, Department of Internal Medicine, Showa University Northern Yokohama Hospital)
4. EPISODE study
Yoshitaka Isaka
(Department of Nephrology, Osaka University Graduate School of Medicine)
5. Clinical research in nephrology: the good, the bad, and ugly
Yoshitsugu Obi
(Division of Nephrology, University of Tennessee Health Science Center)

Special Session<Can Japanese evidence change the world?>2
“Clinical Practice Patterns of ESRD Patients”

Date
13:30-16:00, June 20 (Sun)
Venue
Room 10 (G416+G417, North 4F, PACIFICO YOKOHAMA)
Chairs
Masafumi Fukagawa
(Division of Nephrology, Endocrinology and Metabolism, Tokai University School of Medicine)
Kosaku Nitta
(Tokyo Women's Medical University)
1. What makes Japanese dialysis therapy distinctive in the world - messages from the DOPPS data
Norio Hanafusa
(Department of Blood Purification, Tokyo Women's Medical University)
2. Management of CKD-MBD: Are Japanese different from other populations?
Hirotaka Komaba
(Division of Nephrology, Endocrinology and Metabolism, Tokai University School of Medicine)
3. The management of renal anemia: in the world of iron deficiency and in the world of iron overload
Takayuki Hamano
(Department of Nephrology, Nagoya City University Graduate School of Medical Sciences)
4. Is predilution on-line hemodiafiltration the best dialysis modality? Then, for what?
Ikuto Masakane
(Department of Nephrology, Yabuki Hospital)
5. Selection and management of vascular access: Is fistula the best?
Motonobu Nakamura
(Division of Nephrology and Endocrinology, The University of Tokyo)
6. Decision making for initiation and withholding renal replacement therapy among Japanese end stage kidney disease patients: Special consideration of culture and super aging society
Yasuhiro Komatsu
(Department of Healthcare Quality and Safety, Gunma University Graduate School of Medicine)

Symposium 1 “Science of Uremic Toxins”

Date
9:00-11:00, June 18 (Fri)
Venue
Room 3 (G303+G304, North 3F, PACIFICO YOKOHAMA)
Chairs
Reiko Inagi
(Division of CKD Pathophysiology, The University of Tokyo, Graduate School of Medicine)
Suguru Yamamoto
(Niigata University Medical and Dental Hospital)
1. Gut microbiota, diet, and chronic kidney disease
Wendy S. Garrett
(Harvard T.H. Chan School of Public Health)
2. TBD
Takaaki Abe
(Department of Clinical Biology and Hormonal Regulation, Tohoku University School of medicine)
3. Sarcopenia and uremic toxins
Hiroshi Watanabe
(Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Kumamoto University)
4. Uremic toxins- related bone metabolic disorder in chronic kidney disease
Yoshiko Iwasaki
(Department of Health Sciences, Oita University of Nursing and Health Sciences)
5. Interactions between the nervous system and the kidney
Shinji Tanaka
(University of Virginia, Division of Nephrology and the Center for Immunity, Inflammation and Regenerative Medicine)

International comparison in epidemiology of chronic kidney disease

*Onsite and Live streaming only

Date
9:00-10:30, June 20 (Sun)
Venue
Room 10 (G416+G417, North 4F, PACIFICO YOKOHAMA)
Chairs
Harold I. Feldman
(Center for Clinical Epidemiology and Biostatistics, and University of Pennsylvania / Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania)
Naohiko Fujii
(Department of Nephrology, Hyogo Prefectural Nishinomiya Hospital)
1. International collaboration of chronic kidney disease cohort studies: iNET-CKD network
Harold I. Feldman
(Center for Clinical Epidemiology and Biostatistics, and University of Pennsylvania / Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania)
2. Association between Serum Indices of Iron Metabolism and Cardiovascular Morbidity in Patients with Predialysis Chronic Kidney Disease
Takeshi Hasegawa
(Showa University Research Administration Center (SURAC), Showa University, Division of Nephrology, Department of Medicine, School of Medicine, Showa University)
3. Etiological information for risk stratification of chronic kidney disease based on past kidney biopsy
Takayuki Hamano
(Department of Nephrology Nagoya City University Graduate School of Medical Sciences)
4. Socioeconomic status and prognosis of patients with predialysis chronic kidney disease in Japan
Naohiko Fujii
(Department of Nephrology, Hyogo Prefectural Nishinomiya Hospital)
5. CVD prevalence and β-blocker prescribing in CKD: A comparison between Japan and the United States
Takahiro Imaizumi
(Department of Advanced Medicine, Nagoya University Hospital / Department of Nephrology, Nagoya University Graduate School of Medicine)

Asian session・APSN CME Joint symposium “Asian nephrology after COVID-19”

Date
9:00-11:00, June 18 (Fri)
Venue
Room 10 (G416+G417, North 4F, PACIFICO YOKOHAMA)
Chairs
Xue-Qing Yu
(APSN CME Committee Chair)
Masaomi Nangaku
(President of APSN)
1. JSN post COVID-19: JSN's approach to the COVID-19 pandemic
Naoki Kashihara
(President of JSN)
2. APSN post COVID-19: Looking into the Asia Pacific region of post COVID-19 era
Masaomi Nangaku
(President of APSN)
3. KSN post COVID-19: The Strategy of Korean Society of Nephrology to Overcome COVID19
Chul Woo Yang
(President of KSN)
4. TSN post COVID-19
Shang-Jyh Hwang
(President of TSN)

JSN/ASN Joint Symposium

Date
9:00-11:00, June 19 (Sat)
Venue
Room 10 (G416+G417, North 4F, PACIFICO YOKOHAMA)
Chairs
Susan E. Quaggin
(Northwestern University)
Naoki Kashihara
(Department of Nephrology/Hypertension, Kawasaki Medical School)
1. TBD
Susan E. Quaggin
(Northwestern University)
2. TBD
3. TBD
Naoki Kashihara
(Department of Nephrology/Hypertension, Kawasaki Medical School)
4. Fate and consequence of podocyte injury
Taiji Matsusaka
(Department of Basic Medicine, Tokai University School of Medicine)

JSN/ERA-EDTA Joint Symposium

Date
15:00-17:00, June 19 (Sat)
Venue
Room 10 (G416+G417, North 4F, PACIFICO YOKOHAMA)
Chairs
Mårten Segelmark
(Lund University)
Motoko Yanagita
(Department of Nephrology, Graduate School of Medicine, Kyoto University)
1. Reconsideration of dissimilarity in European and Japanese IgA nephropathy
Yusuke Suzuki
(Department of Nephrology, Juntendo University Graduate School of Medicine)
2. Removal of autoantibodies in rapidly progressive glomerulonephritis-with plasma exchance, with exzymatic degradation or not all?
Mårten Segelmark
(Lund University)
3. Clinical outcomes of lupus nephritis in Japan: results from a nationwide registry
Keiju Hiromura
(Department of Nephrology and Rheumatology, Gunma University)
4. Rituximab treatment in MCD and FSGS: what are the evidences and mechanisms of action
Andreas Kronbicher
(Department of Medicine, University of Cambridge)
5. RNA targeted therapies in kidney disease
Maria Vanessa Pérez-Gómez
(Fundación Jiménez Díaz University Hospital)
6. Role of macrophages in the protective effect of the kidney through the autonomic nervous system
Tsuyoshi Inoue
(Department of Physiology of Visceral Function and Body Fluid, Graduate School of Biomedical Sciences, Nagasaki University)

JSN/KDIGO Joint Symposium

Date
16:00-18:00, June 18(Fri)
Venue
Room 10 (G416+G417, North 4F, PACIFICO YOKOHAMA)
Chairs
Yusuke Tsukamoto
(Department of Nephrology, IMS Itabashi Chuo Medical Center)
Kunitoshi Iseki
(Nakamura Clinic, Clinical Research Support Center)
1. AKD as a new concept
Paul E Stevens
(East Kent Hospitals University NHS Foundation Trust)
2. Participation in "KDIGO in Genetics" working group as a researcher
Kandai Nozu
(Kobe University Graduate School of Medicine)
3. Participating in KDIGO Conference on ADPKD Guidance as a Patient
Kaori Yamane Winston
(PKDFCJ)

JSN/KDIGO session on DKD

Date
10:30-12:00, June 20 (Sun)
Venue
Room 10 (G416+G417, North 4F, PACIFICO YOKOHAMA)
Chairs
Takashi Wada
(Department of Nephrology and Laboratory Medicine, Kanazawa University)
Shin-ichi Araki
(Department of Medicine, Division of Diabetology, Endocrinology, and Nephrology, Shiga University of Medical Science)
1. KDIGO Guideline on Diabetes Management in Chronic Kidney Disease
Adrian Liew
(Mount Elizabeth Novena Hospital)
2. Early Identification and Intervention in CKD
Magdalena Madero Rovalo
(National Institute of Cardiology Ignacio Chavez)
3. Japanese clinicopathological evidence on DKD
Kengo Furuichi
(Kanazawa Medical University Department of Nephrology)

Oshima Award Lecture

Date
13:30-14:00, June 18 (Fri)
Venue
Room 1 (G3+G4, North 1F, PACIFICO YOKOHAMA)
Chair
Yoshitaka Isaka
(Department of Nephrology, Osaka University Graduate School of Medicine)
1. Generation of interspecies chimeric nephrons from renal progenitor cells using developmental organ niche
Shuichiro Yamanaka
(Department of Internal Medicine, Division of Nephrology and Hypertension, Jikei University School of Medicine)
2. DNA damage repair and altered epigenome in the kidney: as useful markers and therapeutic targets
Kaori Hayashi
(Division of Nephrology, Endocrinology and Metabolism, Department of Internal Medicine, Keio University School of Medicine)

CSA (Clinical Scientist Award) Lecture

Date
14:00-14:30, June 18 (Fri)
Venue
Room 1 (G3+G4, North 1F, PACIFICO YOKOHAMA)
Chair
Keiko Uchida
(Tokyo Women's Medical University)
1. The Emerging Role of Magnesium in CKD
Yusuke Sakaguchi
(Department of Inter-Organ Communication Research in Kidney Diseases, Osaka University)
2. A tight link between CKD-MBD and malnutrition-inflammation complex syndrome (MICS) in patients receiving hemodialysis
Shunsuke Yamada
(Department of Nephrology, Hypertension, and Strokology, Kyushu University)

YIA (Young Investigator Award) Session

Date
14:00-14:45, June 20 (Sun)
Venue
Room 4 (G314+G315, North 3F, PACIFICO YOKOHAMA)
Chairs
Akira Nishiyama
(Dept. of Pharmacology, Faculty of Medicine, Kagawa University)
Shinji Kume
(Shiga University of Medical Science)
1. Effects of canagliflozin on anemia in patients with type 2 diabetes and chronic kidney disease
Megumi Oshima
(Department of Nephrology and Laboratory Medicine, Kanazawa University,)
2. Cell profiling of mouse acute kidney injury reveals conserved cellular responses to injury
Yuhei Kirita
(Department of Nephrology, Kyoto Prefectural University of Medicine)
3. Profibrotic circulating proteins and risk of early progressive renal decline in Type 2 Diabetes patients with and without albuminuria
Katsuhito Ihara
(Tokyo Medical and Dental University / Joslin Diabetes center Harvard medical school)

Best Abstract Session – Basic 1 (Regular submission)

Date
9:00-10:00, June 20 (Sun)
Venue
Room 4 (G314+G315, North 3F, PACIFICO YOKOHAMA)
Chairs
Miki Nagase
(Kyorin University)
Katsuhiko Asanuma
(Chiba University)
1.【BA-01】Long-lasting glucose-independent renoprotective effects by pulse therapy with nicotinamide mononucleotide in early stage of diabetic nephropathy
Itaru Yasuda
(Department of Internal Medicine, School of Medicine, Keio University)
2.【BA-02】T-cell repertoire in tonsil of IgA nephropathy
Kazunori Satokata
(Division of Clinical Nephrology and Rheumatology, Kidney Research Center, Niigata University Graduate School of Medical and Dental Sciences)
3.【BA-03】Intravital ATP imaging reveals a pathophysiological mechanism for podocyte injury after ischemic reperfusion injury
Masahiro Takahashi
(Department of Nephrology, Graduate School of Medicine, Kyoto University)
4.【BA-04】The difference of the disease mechanism for focal segmental glomerulosclerosis due to the variance of the MAFB gene mutation position
Toshiaki Usui
(Department of Nephrology, Faculty of Medicine, University of Tsukuba)
5.【BA-05】Treatment with antisense-oligonucleotide or splicing regulating proteins for X-linked Alport syndrome cases with deep intronic variants
Tomoko Horinouchi
(Department of Pediatrics, Kobe University Graduate School of Medicine)

Best Abstract Session – Basic 2 (Regular submission)

Date
9:00-11:00, June 20 (Sun)
Venue
Room 4 (G314+G315, North 3F, PACIFICO YOKOHAMA)
Chairs
Ryuihi Nishinakamura
(Kumamoto University)
Takashi Yokoo
(The Jikei University School of Medicine)
1.【BA-06】Alox15 knock-out mice show improvement of kidney dysfunction and fibrosis in chronic kidney disease by increased PGD2 in the kidney
Naohiro Takahashi
(Department of Nephrology, Tokyo Medical and Dental University)
2.【BA-07】Renal congestion accelerates ischemia-reperfusion acute kidney injury
Takashi Kitani
(Department of Nephrology, Kyoto Prefectural University of Medicine)
3.【BA-08】Single-cell analysis of phosphate-induced kidney injury
Yusuke Katsuma
(Department of Nephrology, Osaka University Graduate School of Medicine)
4.【BA-09】Dietary magnesium insufficiency induces salt-sensitive hypertension in mice associated with reduced kidney COMT activity
Asako Kumagai (Department of Obstetrics and Gynecology, Juntendo University)
5.【BA-10】miRNA expression profiling in age-dependent renal impairment
Katsunori Yanai
(Saitama Medical Center, Jichi Medical University)

Best Abstract Session – Clinical (Regular submission)

Date
11:00-12:00, June 20 (Sun)
Venue
Room 4 (G314+G315, North 3F, PACIFICO YOKOHAMA)
Chairs
Koichi Asahi
(Iwate Medical University)
Jyunichi Hoshino
(Toranomon Hospital)
1.【BA-11】The distribution of eGFR by age in healthy community-based population
Araumi Akira
(Department of Nephrology and Rheumatology, Yamagata University)
2.【BA-12】Association between albuminuria and diabetic nephropathy lesions in autopsy cases with diabetes mellitus : the Hisayama Study
Takaya Sasaki
(Department of Epidemiology and Public Health, Kyushu University)
3.【BA-13】Sodium-glucose cotransporter 2 inhibitors (SGLT2i) use and anemia in diabetic CKD
Miho Murashima
(Nagoya City University)
4.【BA-14】Burden of Kidney Disease on Discrepancy between Reasons for Admission and Death: A Nationwide Cohort Study of Japanese Adults
Shintaro Mandai
(Nephrology, Tokyo Medical and Dental University)
5.【BA-15】Clinical effects of aldosterone receptor antagonists in dialysis patients: a systematic review
Takeshi Hasegawa
(Showa University Research Administration Center)

Late Breaking Abstracts

Date
14:45-16:00, June 20 (Sun)
Venue
Room 4 (G314+G315, North 3F, PACIFICO YOKOHAMA)
Chairs
Shinichi Uchida
(Department of Nephrology, Tokyo Medical and Dental University)
Daijo Inaguma
(Department of Internal Medicine, Fujita Health University Bantane Hospital)
1.【LBA-1】Renal NG2-expressing cells have macrophage-like activity and facilitate renal recovery after ischemic injury
Wararat Kittikulsuth
(Department of Pharmacology, Kagawa University)
2.【LBA-2】False-negative diagnosis of high anion gap in patients with end-stage kidney disease
Masato Ikeda
(Division of Nephrology and Hypertension, The Jikei University School of Medicine Kashiwa Hospital)
3.【LBA-3】Low Phosphorus Meals Decrease Blood CKD-MBD Indicators and Inflammatory Cytokine in Maintenance Hemodialysis Patients
Barbara Ying-Jung Chen
(School of Nutrition and Health Science, Taipei Medical University)
4.【LBA-4】Polypharmacy, CKD, and incident fracture: a Japanese hospital-based cohort study from the Project in Sado for Total Health (PROST)
Minako Wakasugi
(Department of Inter-Organ Communication Research, Niigata University Graduate School of Medical and Dental Sciences)
5.【LBA-5】Temporal Change of Serum Anti-SARS-CoV-2 IgG Antibody Levels in Hemodialysis Patients with COVID-19
Hiroko Beppu
(Department of Nephrology, Tokyo Metropolitan Health and Medical Treatment Corporation Ohkubo Hospital)
5.【LBA-6】Clinical course of kidney injury in hospitalized patients with mild or moderate COVID-19
Lisa Uchida
(Department of Nephrology, JCHO Tokyo Shinjuku Medical Center)

CKD-English (Regular submission)

Date
11:00-12:00, June 20 (Sun)
Venue
Room 5 (G316+G317, North 3F, PACIFICO YOKOHAMA)
Chairs
Yusuke Tsukamoto
(Itabashi Chuo Medical Center)
Yoshinari Yasuda
(Nagoya University)
1.【O-162】Compliance and adherence to drug treatment on patients with Chronic Kidney Disease (CKD) in high prevalence areas of North Central Province, Sri Lanka
N. A. Sanjeewani
(Department of Pharmacy, General Sir John Kotelawala Defence University)
2.【O-163】Association of eGFR index category and annual slope with adverse clinical outcomes in Japan
Keizo Kanasaki
(Internal Medicine 1, Faculty of Medicine, Shimane University)
3.【O-164】Effect of Daratumumab (DARA) + Bortezomib, Cyclophosphamide, Dexamethasone (VCd) on Renal Organ Response and Health-Related Quality of Life (HRQoL) in Patients With Systemic Light Chain (AL) Amyloidosis: ANDROMEDA Japanese Subgroup
Andrea Havasi
(Boston University School of Medicine)
4.【O-165】Mineralocorticoid Receptor Antagonist and Hard Renal Outcome in a Real-World CKD Population: A Marginal Structural Model Analysis
Tatsufumi Oka
(Department of Nephrology, Osaka University)
5.【O-166】Circulating Proteins as Prognostic Biomarkers of End-stage Kidney Disease in Diabetes
Katsuhito Ihara
(Joslin Diabetes Center, Harvard Medical School)